Joel Greenblatt acquired 60.9 Thousand Twist Bioscience shares worth $2.86 Million. That's 0.04% of their equity portfolio (525th largest holding). The stake costed the investor $1.35 Million, netting the investor a gain of 112% so far.
Avg closing price
Price range
Increased shares by 10.5% (+5.79 Thousand shares)
Q1 2024
Avg closing price
$36.10
Price range
$32.28
-
$41.50
Increased shares by 29.3% (+12.5 Thousand shares)
Q4 2023
Avg closing price
$23.12
Price range
$15.08
-
$38.61
Increased shares by 253.2% (+30.5 Thousand shares)
Q3 2023